Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 22 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 8609404

    Vaccines containing canine parvovirus genetic variants

    The Board of Regents for Oklahoma State University · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  2. US 8603808

    Leishmania vaccine using sand fly salivary immunogen

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  3. US 8591890

    Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

    University of Connecticut Health Center · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

  4. US 8575319

    Cleavable vaccine compositions and uses thereof and methods of making and using the same

    The Regents of the University of California · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  5. US 8535687

    Smallpox DNA vaccine and the antigens therein that elicit an immune response

    Inovio Pharmaceuticals, Inc. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  6. US 8501926

    Malaria vaccine

    The United States of America as represented by the Secretary of the Army · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  7. US 8501194

    Vaccine for viruses that cause persistent or latent infections

    The Regents of the University of California · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  8. US 8496938

    Anti-CD100 neutralizing neutralizing antibodies and methods of using the same

    VACCINEX, INC. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  9. US 8481693

    Virus like particle purification

    Takeda Vaccines (Montana), Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  10. US 8481024

    Vaccines against tularemia

    The Regents of the University of California · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  11. US 8465749

    Polysaccharide-protein conjugate vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  12. US 8455621

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  13. US 8444996

    Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 21, 2013 · Expires May 16, 2033

    granted

  14. US 8444991

    Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

    The Regents of the University of Colorado, a Body Corporate · Granted May 21, 2013 · Expires May 16, 2033

    granted

  15. US 8445254

    Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 21, 2013 · Expires May 16, 2033

    granted

  16. US 8440205

    Streptococcal C5A peptidase vaccine

    Regents of the University of Minnesota · Granted May 14, 2013 · Expires May 9, 2033

    granted

  17. US 8435507

    Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer

    The United States of America as Represented by the Dept. of Veterans Affairs · Granted May 7, 2013 · Expires May 2, 2033

    granted

  18. US 8431116

    Norovirus vaccine formulations

    Takeda Vaccines (Montana), Inc. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  19. US 8426575

    N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  20. US 8420107

    Peptide vaccines against group A streptococci

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  21. US 8420072

    Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an inactivated Vibrio vulnificus vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  22. US 8399610

    HPV vaccine comprising peptides from host cell proteins

    University College Cardiff Consultants Limited · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted

  23. US 8394387

    Recombinant modified Bacillus anthracis protective antigen for use in vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted

  24. US 8383133

    Conjugates of Plasmodium falciparum surface proteins as malaria vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.